The Latest: Is 90% effective too good to be true?
There’s a lot of really good and really bad news related to Covid-19 this week. Let’s start with the good news: Pfizer and BioNTech released data suggesting that its vaccine is more than 90% effective at preventing Covid-19. There are caveats, which you can read here, but there are also real reasons to be optimistic. Dr. Anthony Fauci recently said a vaccine could be available to all Americans by April 2021.
The bad news is that heading into the holiday season, cases of Covid-19 continue to spread widely. U.S. hospitalizations from the virus hit a record high of nearly 62,000 on Tuesday, and new daily cases passed 139,000 for the first time. With a potential vaccine on the horizon, now is the time to be cautious.
P.S. Today I published a story about the success of Covid-19 long haulers at building a patient-led health movement. You can check it out here.
Here’s what else is new:
- Eli Lilly’s monoclonal antibody gets FDA emergency authorization: The decision applies only to people newly infected with the virus and came with a warning that it should not be used in hospitalized patients, the New York Times reports.
- Biden names Covid-19 crisis team: The taskforce will be led by three co-chairs: former Surgeon General Vivek Murthy, former Food and Drug Administration Commissioner David Kessler, and Dr. Marcella Nunez-Smith from Yale University. Read more.
- More of Trump’s circle tests positive for Covid-19: Trump adviser David Bossie tested positive for the virus. Housing and Urban Development Secretary Ben Carson also tested positive recently.
Follow our Medium Coronavirus Blog for regular updates, and read some of the essential stories we’ve curated below.
Editor, Medium Coronavirus Blog
Was this email forwarded to you by a friend? Sign up to receive regular updates from our Coronavirus Team in your inbox.
New on the blog
There’s a lot! Let me break it down for you: